Literature DB >> 18493770

Improved rheumatoid digital vasculitis in a patient treated with TNFalpha agent blocking (infliximab).

Maurizio Benucci1, Francesca Li Gobbi, Gianantonio Saviola, Mariangela Manfredi.   

Abstract

Rheumatoid vasculitis (RV) is an uncommon but potentially catastrophic complication of rheumatoid arthritis (RA). There are few current extensive studies and no consensus regarding the clinical, laboratory, histologic features and management or prognosis of RV. We report a case of RV in a 74-year old woman with a long (14 years) history of RA, who developed vasculitis of distal arteries with gangrene of digits of upper and lower extremities. After the failure of various immunosuppressive drugs (cyclophosphamide, methotrexate), the patient was treated with anti-TNFalpha infliximab. Digital gangrene healed within four months from the start of anti-TNFalpha treatment.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18493770     DOI: 10.1007/s00296-008-0592-x

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  15 in total

1.  Successful treatment of refractory mononeuritis multiplex secondary to rheumatoid arthritis with the anti-tumour necrosis factor alpha monoclonal antibody infliximab.

Authors:  C Garcia-Porrua; M A González-Gay
Journal:  Rheumatology (Oxford)       Date:  2002-02       Impact factor: 7.580

Review 2.  Diversity and duplicity: human FCgamma receptors in host defense and autoimmunity.

Authors:  Robert P Kimberly; Jianming Wu; Andrew W Gibson; Kaihong Su; Hongwe Qin; Xiaoli Li; Jeffrey C Edberg
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

Review 3.  Systemic rheumatoid vasculitis: a review.

Authors:  Marcia S Genta; Robert M Genta; Cem Gabay
Journal:  Semin Arthritis Rheum       Date:  2006-10       Impact factor: 5.532

4.  The frequency of cutaneous vasculitis is not increased in patients with rheumatoid arthritis treated with methotrexate.

Authors:  O Kaye; C C Beckers; P Paquet; J E Arrese; G E Piérard; M G Malaise
Journal:  J Rheumatol       Date:  1996-02       Impact factor: 4.666

5.  Cutaneous necrotizing vasculitis after low dose methotrexate therapy for rheumatoid arthritis: a possible manifestation of methotrexate hypersensitivity.

Authors:  T Simonart; P Durez; J Margaux; J Van Geertruyden; D Goldschmidt; D Parent
Journal:  Clin Rheumatol       Date:  1997-11       Impact factor: 2.980

Review 6.  C-ANCA positive systemic vasculitis in a patient with rheumatoid arthritis treated with infliximab.

Authors:  Dayavathi Ashok; Shirish Dubey; Ian Tomlinson
Journal:  Clin Rheumatol       Date:  2007-08-22       Impact factor: 2.980

7.  Intravenous cyclophosphamide plus methylprednisolone in treatment of systemic rheumatoid vasculitis.

Authors:  D G Scott; P A Bacon
Journal:  Am J Med       Date:  1984-03       Impact factor: 4.965

8.  Labial salivary gland biopsy assessment in rheumatoid vasculitis.

Authors:  R M Flipo; A Janin; E Hachulla; E Houvenagel; A Foulet; T Cardon; A Desbonnet; B Grardel; B Duquesnoy; B Delcambre
Journal:  Ann Rheum Dis       Date:  1994-10       Impact factor: 19.103

9.  Correlation of serum IgA rheumatoid factor levels with disease severity in rheumatoid arthritis.

Authors:  S Päi; L Päi; R Birkenfeldt
Journal:  Scand J Rheumatol       Date:  1998       Impact factor: 3.641

10.  Rheumatoid factors in rheumatoid arthritis and vasculitis.

Authors:  M L Westedt; P Herbrink; J L Molenaar; E de Vries; P Verlaan; T Stijnen; A Cats; J Lindeman
Journal:  Rheumatol Int       Date:  1985       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.